Ultrasound contrast developer Acusphere said that senior vice president of clinical research Dr. Richard Walovitch has resigned to pursue another opportunity.
Walovitch's 11-year tenure at Acusphere will come to an end January 9, according to the Watertown, MA-based vendor.
Related Reading
FDA panel rejects Acusphere contrast agent, December 11, 2008
FDA 'concerned' over Acusphere agent, December 9, 2008
Bernstein leaves Acusphere, November 18, 2008
Acusphere's Imagify to get FDA review, October 13, 2008
Acusphere taps new VP, September 25, 2008
Copyright © 2009 AuntMinnie.com